Publication | Closed Access

A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide 11Ms. Clineschmidt, Dr. Adamsons, Dr. Snyder, and Dr. Reines are employees of Merck & Co., Inc., the manufacturer of the dorzolamide-timolol combination. The other authors have no proprietary interest in the dorzolamide-timolol combination or in Merck.

Dr. SnyderClinical TherapeuticSystemic TreatmentPharmacologyClinical TrialsDorzolamide-timolol CombinationTherapeutic ControversyPharmacotherapyRandomized TrialMedicine